These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33735526)

  • 1. Progressive myoclonus epilepsy KCNC1 variant causes a developmental dendritopathy.
    Carpenter JC; Männikkö R; Heffner C; Heneine J; Sampedro-Castañeda M; Lignani G; Schorge S
    Epilepsia; 2021 May; 62(5):1256-1267. PubMed ID: 33735526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutations.
    Nascimento FA; Andrade DM
    Epileptic Disord; 2016 Sep; 18(S2):135-138. PubMed ID: 27629860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive myoclonic epilepsy: myoclonic epilepsy and ataxia due to KCNC1 mutation (MEAK): a case report and review of the literature.
    Barot N; Margiotta M; Nei M; Skidmore C
    Epileptic Disord; 2020 Oct; 22(5):654-658. PubMed ID: 32972906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial cases of progressive myoclonic epilepsy caused by maternal somatic mosaicism of a recurrent KCNC1 p.Arg320His mutation.
    Kim H; Lee S; Choi M; Kim H; Hwang H; Choi J; Chae JH; Kim KJ; Lim BC
    Brain Dev; 2018 May; 40(5):429-432. PubMed ID: 29428275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoclonus epilepsy and ataxia due to KCNC1 mutation: Analysis of 20 cases and K
    Oliver KL; Franceschetti S; Milligan CJ; Muona M; Mandelstam SA; Canafoglia L; Boguszewska-Chachulska AM; Korczyn AD; Bisulli F; Di Bonaventura C; Ragona F; Michelucci R; Ben-Zeev B; Straussberg R; Panzica F; Massano J; Friedman D; Crespel A; Engelsen BA; Andermann F; Andermann E; Spodar K; Lasek-Bal A; Riguzzi P; Pasini E; Tinuper P; Licchetta L; Gardella E; Lindenau M; Wulf A; Møller RS; Benninger F; Afawi Z; Rubboli G; Reid CA; Maljevic S; Lerche H; Lehesjoki AE; Petrou S; Berkovic SF
    Ann Neurol; 2017 May; 81(5):677-689. PubMed ID: 28380698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological rescue of mutated K
    Munch AS; Saljic A; Boddum K; Grunnet M; Hougaard C; Jespersen T
    Eur J Pharmacol; 2018 Aug; 833():255-262. PubMed ID: 29894724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy improves cellular dysfunction, ataxia, and seizure susceptibility in a model of a progressive myoclonus epilepsy.
    Feng H; Clatot J; Kaneko K; Flores-Mendez M; Wengert ER; Koutcher C; Hoddeson E; Lopez E; Lee D; Arias L; Liang Q; Zhang X; Somarowthu A; Covarrubias M; Gunthorpe MJ; Large CH; Akizu N; Goldberg EM
    Cell Rep Med; 2024 Feb; 5(2):101389. PubMed ID: 38266642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A KCNC1-related neurological disorder due to gain of Kv3.1 function.
    Clatot J; Ginn N; Costain G; Goldberg EM
    Ann Clin Transl Neurol; 2023 Jan; 10(1):111-117. PubMed ID: 36419348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encephalopathies with KCNC1 variants: genotype-phenotype-functional correlations.
    Cameron JM; Maljevic S; Nair U; Aung YH; Cogné B; Bézieau S; Blair E; Isidor B; Zweier C; Reis A; Koenig MK; Maarup T; Sarco D; Afenjar A; Huq AHMM; Kukolich M; Billette de Villemeur T; Nava C; Héron B; Petrou S; Berkovic SF
    Ann Clin Transl Neurol; 2019 Jul; 6(7):1263-1272. PubMed ID: 31353855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
    Muona M; Berkovic SF; Dibbens LM; Oliver KL; Maljevic S; Bayly MA; Joensuu T; Canafoglia L; Franceschetti S; Michelucci R; Markkinen S; Heron SE; Hildebrand MS; Andermann E; Andermann F; Gambardella A; Tinuper P; Licchetta L; Scheffer IE; Criscuolo C; Filla A; Ferlazzo E; Ahmad J; Ahmad A; Baykan B; Said E; Topcu M; Riguzzi P; King MD; Ozkara C; Andrade DM; Engelsen BA; Crespel A; Lindenau M; Lohmann E; Saletti V; Massano J; Privitera M; Espay AJ; Kauffmann B; Duchowny M; Møller RS; Straussberg R; Afawi Z; Ben-Zeev B; Samocha KE; Daly MJ; Petrou S; Lerche H; Palotie A; Lehesjoki AE
    Nat Genet; 2015 Jan; 47(1):39-46. PubMed ID: 25401298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK): a cause of progressive myoclonic epilepsy.
    Mahale RR; Tiwari R; Arunachal G; Padmanabha H; Mailankody P
    Acta Neurol Belg; 2022 Jun; 122(3):801-803. PubMed ID: 33725338
    [No Abstract]   [Full Text] [Related]  

  • 12. Utilising Automated Electrophysiological Platforms in Epilepsy Research.
    Milligan CJ; Pachernegg S
    Methods Mol Biol; 2021; 2188():133-155. PubMed ID: 33119850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCNC1-related disorders: new de novo variants expand the phenotypic spectrum.
    Park J; Koko M; Hedrich UBS; Hermann A; Cremer K; Haberlandt E; Grimmel M; Alhaddad B; Beck-Woedl S; Harrer M; Karall D; Kingelhoefer L; Tzschach A; Matthies LC; Strom TM; Ringelstein EB; Sturm M; Engels H; Wolff M; Lerche H; Haack TB
    Ann Clin Transl Neurol; 2019 Jul; 6(7):1319-1326. PubMed ID: 31353862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A KCNC1 mutation in epilepsy of infancy with focal migrating seizures produces functional channels that fail to be regulated by PKC phosphorylation.
    Zhang Y; Ali SR; Nabbout R; Barcia G; Kaczmarek LK
    J Neurophysiol; 2021 Aug; 126(2):532-539. PubMed ID: 34232791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Function of KCNC1 is associated with intellectual disability without seizures.
    Poirier K; Viot G; Lombardi L; Jauny C; Billuart P; Bienvenu T
    Eur J Hum Genet; 2017 May; 25(5):560-564. PubMed ID: 28145425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kv3.1 channelopathy: a novel loss-of-function variant and the mechanistic basis of its clinical phenotypes.
    Li X; Zheng Y; Li S; Nair U; Sun C; Zhao C; Lu J; Zhang VW; Maljevic S; Petrou S; Lin J
    Ann Transl Med; 2021 Sep; 9(18):1397. PubMed ID: 34733949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K
    Boddum K; Hougaard C; Xiao-Ying Lin J; von Schoubye NL; Jensen HS; Grunnet M; Jespersen T
    Neuropharmacology; 2017 May; 118():102-112. PubMed ID: 28242439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of induced pluripotent stem cell GZHMCi001-A and GZHMCi001-B derived from peripheral blood mononuclear cells of epileptic patients with KCNC1 mutation.
    Nengqing L; Dian L; Yingjun X; Yi C; Lina H; Diyu C; Yinghong Y; Bing S; Xiaofang S
    Stem Cell Res; 2020 Jul; 47():101897. PubMed ID: 32712483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoclonus improvement after seizures in progressive myoclonic epilepsy type 7: a case report.
    G S B Lima PL; Nobrega PR; Freua F; Braga-Neto P; Paiva ARB; Guimarães TG; Kok F
    BMC Neurol; 2024 May; 24(1):169. PubMed ID: 38783211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of Kv3.1b and Kv3.2 potassium channel subunits in interneurons of the basolateral amygdala.
    McDonald AJ; Mascagni F
    Neuroscience; 2006; 138(2):537-47. PubMed ID: 16413129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.